Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya

Abstract Background The scale-up of HIV treatment programs has resulted in a reduction in HIV-related morbidity and mortality. However, retention of patients in these programs remains a challenge in sub-Saharan Africa. Understanding factors associated with loss to follow-up (LTFU) and mortality outc...

Full description

Bibliographic Details
Main Authors: Paul Wekesa, Angela McLigeyo, Kevin Owuor, Jonathan Mwangi, Evelyne Nganga, Kenneth Masamaro
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Public Health
Subjects:
HIV
Online Access:http://link.springer.com/article/10.1186/s12889-020-8426-1
id doaj-a5ef41c4b40346b5b2b8bcc847446775
record_format Article
spelling doaj-a5ef41c4b40346b5b2b8bcc8474467752020-11-25T02:24:19ZengBMCBMC Public Health1471-24582020-03-0120111110.1186/s12889-020-8426-1Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central KenyaPaul Wekesa0Angela McLigeyo1Kevin Owuor2Jonathan Mwangi3Evelyne Nganga4Kenneth Masamaro5Centre for Health SolutionsCentre for Health SolutionsCentre for Health SolutionsDivision of Global HIV & TB, Centers for Disease Control and Prevention (CDC)Centre for Health SolutionsDivision of Global HIV & TB, Centers for Disease Control and Prevention (CDC)Abstract Background The scale-up of HIV treatment programs has resulted in a reduction in HIV-related morbidity and mortality. However, retention of patients in these programs remains a challenge in sub-Saharan Africa. Understanding factors associated with loss to follow-up (LTFU) and mortality outcomes is therefore important to inform targeted program interventions. Methods A retrospective multi-cohort analysis of 23,890 adult patients on ART over 36 months of follow-up in Kenya was done. Multivariate logistic regression analysis was done to assess for factors associated with LTFU and mortality at 6, 12, 24, and 36 months of follow-up. Results Majority, 67.7%, were female. At 36 months, 27.2% were LTFU and 13.5% had died. Factors associated with mortality at 36 months included older age (51 years and above) using 20–35 years as reference [(adjusted odds ratio [aOR], 1.51, 95% confidence interval (CI) 1.23–1.86, p < 0.001], being male (aOR, 1.59, 95% CI 1.39–1.83, p < 0.001), divorced using married as reference (aOR, 1.86, 95% CI 1.56–2.22, p < 0.001), having a body mass index (BMI) score of less than 18.5 kg/m2 using 18.5–24.9 kg/m2 as reference (aOR = 1.79, 95% CI 1.52–2.11, p < 0.001), and, World Health Organization stage III and IV using stage I as the reference (aOR, 1.94, 95% CI 1.43–2.63 and aOR, 4.24, 95% CI 3.06–5.87, p < 0.001 respectively). Factors associated with LTFU at 36 months included being young between 20 and 35 years (aOR, 1.49, 95% CI 1.40–1.59, p < 0.001) using 36–50 years as reference, being male (aOR, 1.19, 95% CI 1.12–1.27, p < 0.001), and being single or divorced using married as reference (aOR, 1.34, 95% CI 1.23–1.45 and aOR, 1.25, 95% CI 1.15–1.36, p < 0.001 respectively). Patients with baseline BMI of less than 18.5 kg/m2 using normal BMI as reference (aOR, 1.68, 95% CI 1.39–2.02, p < 0.001) were also likely to be LTFU. Conclusions Factors associated with LTFU and mortality were generally similar over time. Implementation of programs in similar settings should be tailored to gender, age profiles, nutritional, and, marital status of patients to address LTFU. In addition, programs should focus on the care of older patients to reduce the risk of mortality.http://link.springer.com/article/10.1186/s12889-020-8426-1Antiretroviral therapyHIVKenyaLoss to follow-upMortality
collection DOAJ
language English
format Article
sources DOAJ
author Paul Wekesa
Angela McLigeyo
Kevin Owuor
Jonathan Mwangi
Evelyne Nganga
Kenneth Masamaro
spellingShingle Paul Wekesa
Angela McLigeyo
Kevin Owuor
Jonathan Mwangi
Evelyne Nganga
Kenneth Masamaro
Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya
BMC Public Health
Antiretroviral therapy
HIV
Kenya
Loss to follow-up
Mortality
author_facet Paul Wekesa
Angela McLigeyo
Kevin Owuor
Jonathan Mwangi
Evelyne Nganga
Kenneth Masamaro
author_sort Paul Wekesa
title Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya
title_short Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya
title_full Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya
title_fullStr Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya
title_full_unstemmed Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya
title_sort factors associated with 36-month loss to follow-up and mortality outcomes among hiv-infected adults on antiretroviral therapy in central kenya
publisher BMC
series BMC Public Health
issn 1471-2458
publishDate 2020-03-01
description Abstract Background The scale-up of HIV treatment programs has resulted in a reduction in HIV-related morbidity and mortality. However, retention of patients in these programs remains a challenge in sub-Saharan Africa. Understanding factors associated with loss to follow-up (LTFU) and mortality outcomes is therefore important to inform targeted program interventions. Methods A retrospective multi-cohort analysis of 23,890 adult patients on ART over 36 months of follow-up in Kenya was done. Multivariate logistic regression analysis was done to assess for factors associated with LTFU and mortality at 6, 12, 24, and 36 months of follow-up. Results Majority, 67.7%, were female. At 36 months, 27.2% were LTFU and 13.5% had died. Factors associated with mortality at 36 months included older age (51 years and above) using 20–35 years as reference [(adjusted odds ratio [aOR], 1.51, 95% confidence interval (CI) 1.23–1.86, p < 0.001], being male (aOR, 1.59, 95% CI 1.39–1.83, p < 0.001), divorced using married as reference (aOR, 1.86, 95% CI 1.56–2.22, p < 0.001), having a body mass index (BMI) score of less than 18.5 kg/m2 using 18.5–24.9 kg/m2 as reference (aOR = 1.79, 95% CI 1.52–2.11, p < 0.001), and, World Health Organization stage III and IV using stage I as the reference (aOR, 1.94, 95% CI 1.43–2.63 and aOR, 4.24, 95% CI 3.06–5.87, p < 0.001 respectively). Factors associated with LTFU at 36 months included being young between 20 and 35 years (aOR, 1.49, 95% CI 1.40–1.59, p < 0.001) using 36–50 years as reference, being male (aOR, 1.19, 95% CI 1.12–1.27, p < 0.001), and being single or divorced using married as reference (aOR, 1.34, 95% CI 1.23–1.45 and aOR, 1.25, 95% CI 1.15–1.36, p < 0.001 respectively). Patients with baseline BMI of less than 18.5 kg/m2 using normal BMI as reference (aOR, 1.68, 95% CI 1.39–2.02, p < 0.001) were also likely to be LTFU. Conclusions Factors associated with LTFU and mortality were generally similar over time. Implementation of programs in similar settings should be tailored to gender, age profiles, nutritional, and, marital status of patients to address LTFU. In addition, programs should focus on the care of older patients to reduce the risk of mortality.
topic Antiretroviral therapy
HIV
Kenya
Loss to follow-up
Mortality
url http://link.springer.com/article/10.1186/s12889-020-8426-1
work_keys_str_mv AT paulwekesa factorsassociatedwith36monthlosstofollowupandmortalityoutcomesamonghivinfectedadultsonantiretroviraltherapyincentralkenya
AT angelamcligeyo factorsassociatedwith36monthlosstofollowupandmortalityoutcomesamonghivinfectedadultsonantiretroviraltherapyincentralkenya
AT kevinowuor factorsassociatedwith36monthlosstofollowupandmortalityoutcomesamonghivinfectedadultsonantiretroviraltherapyincentralkenya
AT jonathanmwangi factorsassociatedwith36monthlosstofollowupandmortalityoutcomesamonghivinfectedadultsonantiretroviraltherapyincentralkenya
AT evelynenganga factorsassociatedwith36monthlosstofollowupandmortalityoutcomesamonghivinfectedadultsonantiretroviraltherapyincentralkenya
AT kennethmasamaro factorsassociatedwith36monthlosstofollowupandmortalityoutcomesamonghivinfectedadultsonantiretroviraltherapyincentralkenya
_version_ 1724856230742065152